Amphenol: BofA Global Research raises price objective to $104 from $99
APH•BofA Global Research raised its price objective for Amphenol to $104 from $99.
Related News
Merck names Cressey managing partner Paul Diaz to board effective Nov. 1, 2026
MRK•
Empire Petroleum director Phil E. Mulacek reports $68,978 common share purchase
EP•
Opus Genetics presents at Chardan Annual Healthcare Conference
IRD•
U.S. stocks on the move: Johnson & Johnson, JPMorgan, UnitedHealth, Goldman Sachs
SPY•
Moderna schedules third-quarter 2026 financial results call
MRNA•